FindTrial
Sign In

Comparative analysis of clinical application of lauryl alcohol and bleomycin sclerotherapy in the treatment of oral and maxillofacial hemangioma and vascular malformation

Comparative analysis of clinical application of lauryl alcohol and bleomycin sclerotherapy in the treatment of oral and maxillofacial hemangioma and vascular malformation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050958
Enrollment
Unknown
Registered
2021-09-08
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral and maxillofacial hemangioma and vascular malformation

Interventions

lauryl alcohol sclerotherapy group:Nil
bleomycin sclerotherapy group:Nil

Sponsors

Affiliated Stomatological Hospital of Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. The patient's clinical data are complete; 2. Normal cognitive function.

Exclusion criteria

Exclusion criteria: 1. Vital organ dysfunction; 2. Malignant tumor; 3. Patients with mental disorders.

Design outcomes

Primary

MeasureTime frame
cure rate;—

Countries

China

Contacts

Public ContactHan Chaoying

Affiliated Stomatological Hospital of Zhejiang University School of Medicine

2277478212@qq.com+86 17380408904

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026